Case Report
Accepted on 02 Dec 2024
Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
in Hematologic Malignancies
Case Report
Accepted on 02 Dec 2024
in Hematologic Malignancies
Original Research
Accepted on 02 Dec 2024
in Atherosclerosis and Vascular Medicine
Systematic Review
Accepted on 02 Dec 2024
in Nutritional Epidemiology
Original Research
Accepted on 02 Dec 2024
in Obstetric and Pediatric Pharmacology
Systematic Review
Accepted on 02 Dec 2024
in Inflammation
Original Research
Accepted on 02 Dec 2024
in Plant Pathogen Interactions
Editorial
Accepted on 02 Dec 2024
in Forest Management
Original Research
Accepted on 02 Dec 2024
in Statistical and Computational Physics
Review
Accepted on 02 Dec 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 02 Dec 2024
in Neurotrauma
Systematic Review
Accepted on 02 Dec 2024
in Stroke
Original Research
Accepted on 02 Dec 2024
in Food Microbiology
Original Research
Accepted on 02 Dec 2024
in Medical Physics and Imaging
Original Research
Accepted on 02 Dec 2024
in Gastrointestinal and Hepatic Pharmacology
Original Research
Accepted on 02 Dec 2024
in Plant Pathogen Interactions
Original Research
Accepted on 02 Dec 2024
in Computer Security